Protara Therapeutics, Inc. (TARA)

NASDAQ

$2.63

$+0.14

(+5.71%)

Pre-Market

Protara Therapeutics, Inc. (TARA) Live Price Chart

Last updated: ⁦2026-10-22 12:11:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Protara Therapeutics, Inc. (TARA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2.63, with a market capitalization of $151.28M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.25 to $7.82. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$151.28M
Open	$2.49
Day's High	$67.08
Day's Low	$1.04
Previous Close	$2.50
Volume	32.00
Average Volume	908.10K
P/E Ratio	--
52-Week High	$7.82
52-Week Low	$2.25
Dividend Yield	--
Earnings Date	--

Protara Therapeutics, Inc. (TARA) Pre-Market Stock Price

Protara Therapeutics, Inc. (TARA) is trading at $2.63 in pre-market trading as of 2026-10-22 11:52:00, up 5.16% ($0.13) from the previous close of $2.50

Pre-market trading shows how investors are pricing TARA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Protara Therapeutics, Inc. (TARA) 7-Day Stock Price Change

Over the past seven days, Protara Therapeutics, Inc. (TARA) moved from $2.62 to $2.63, representing a gain of 0.34% ($0.01).

The stock traded between $2.25 and $2.83 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 1.04 million shares, down versus the previous seven-day period, indicating lower trading activity.

TARA 52-Week Price Position

Position in Range: 6.8%

52W Low$2.25

52W High$7.82

TARA is currently trading at $2.63, placing it 6.8% of the way from its 52-week low of $2.25 to its 52-week high of $7.82. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Protara Therapeutics, Inc. (TARA)?

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Protara Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	51
Exchange	NASDAQ
Company Website	https://www.protaratx.com

How to Buy Protara Therapeutics, Inc. (TARA) Stock on MEXC

Eligible investors can buy real shares of Protara Therapeutics, Inc. (TARA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TARA and Place Your Order

Open the RealStocks trading page and search for TARA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Protara Therapeutics, Inc. (TARA) stock price today?

Protara Therapeutics, Inc. (TARA) is currently trading at $ 2.63, up 5.16% ($0.13) from the previous close of $ 2.50. Intraday prices update in real time during regular trading hours.

2.Is TARA stock going up or down today?

As of 2026-10-22 11:52:00, TARA is trading at $ 2.63, up 5.16% ($0.13) from its previous close of $ 2.50. The stock has traded between $ 1.04 and $ 67.08 during today’s regular session. Past price movements do not guarantee future results.

3.What is TARA pre-market price?

As of 2026-10-22 11:52:00, TARA is trading at $ 2.63 in pre-market trading, up 5.16% ($0.13) from the previous close of $ 2.50. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TARA after-hours price?

As of 2026-10-22 11:52:00, TARA is trading at $ 2.54 in after-hours trading, up 1.40% ($0.04) from the regular-session close of $ 2.50. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TARA stock trading now?

TARA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TARA sit relative to its 52-week high and low?

Over the past 52 weeks, TARA has traded between a low of $ 2.25 and a high of $ 7.82. At $ 2.63, the stock is positioned 6.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Protara Therapeutics, Inc. in?

Protara Therapeutics, Inc. (TARA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Protara Therapeutics, Inc.'s market capitalization and where is it listed?

Protara Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 151.28M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TARA valued in terms of P/E ratio and EPS?

TARA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Protara Therapeutics, Inc. pay a dividend?

Protara Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.